Ryan Specialty Holdings, Inc.
RYAN News Today: Stay Updated with the Latest Ryan Specialty Holdings, Inc. News in Real Time
Find RYAN news now at Meyka AI. Stay informed with the latest Ryan Specialty Holdings, Inc. stocks updates, including price news, market analysis, and expert insights.

Craig-Hallum Maintains Buy on comScore (SCOR) March 2026
Craig-Hallum maintains Buy on comScore; SCOR analyst rating upheld after March 18, 2026 bounce-back quarter

RBC Maintains Outperform on Constellation Brands (STZ) March 18, 2026
RBC maintained Outperform on Constellation Brands (STZ) March 18, 2026. STZ analyst rating explained and investor implications

NASA Artemis II April 02: Crewed Launch Succeeds; TLI Decision Near
Artemis II lifts off and heads toward a TLI decision. What this means for investors in Japan, from mission risks to a US$20bn surface-base shift and supplier opportunities.

1147.HK (Edensoft, HKSE) down 6.78% 02 Apr 2026 ahead of earnings: key metrics
1147.HK stock intraday earnings spotlight 02 Apr 2026 — price, forecasts, Meyka AI targets and what to watch

S63.SI stock S$10.99 intraday (02 Apr 2026): AI stocks angle for traders
S63.SI stock intraday update: S$10.99, PE 74.00, Meyka AI forecast S$13.37 (21.65% upside).

April 1: Lionel Carmant Returns to CAQ, Quebec Health Policy Watch
Lionel Carmant returns to the CAQ ahead of the April 12 leadership vote. We explain what this means for Quebec health policy, provider pay, hospitals, suppliers, and investors in Canada.

Jefferies Maintains Buy for CTMX (CytomX Therapeutics) March 18, 2026
Jefferies maintained Buy on CTMX March 18, 2026. Read CTMX analyst rating, $16 PT, and Meyka AI grade B+

V-cube (3681.T JPX) drops 41.67% to JPY 70.00 intraday on 02 Apr 2026: Key levels
Intraday report: 3681.T stock down 41.67% to JPY 70 on 02 Apr 2026, analysis of drivers, outlook and Meyka AI forecast

Leerink Maintains Outperform on BrightSpring Health Services (BTSG) March 2026
Leerink maintained Outperform on BrightSpring (BTSG) on March 18, 2026 — coverage and investor implications for BTSG analyst rating